Adjuvant Chemoradiation Therapy for Pancreatic Adenocarcinoma: Who Really Benefits? Discussion

被引：0
|
作者：
Yeo, Charles J.
Fleming, Jason B.
Bolton, John S.
Nealon, William H.
Koniaris, Leonidas G.
McMasters, Kelly M.
O'Neill, James A., Jr.
Merchant, Nipun B.
机构：
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2009年 / 208卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：838 / 841
页数：4
相关论文
共 50 条
  • [21] Safety and Efficacy of Adjuvant Chemoradiation Therapy With Capecitabine After Resection of Pancreatic Ductal Adenocarcinoma A Retrospective Review
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Lee, Jong Kyun
    Lee, Kyu Taek
    Lee, Kwang Hyuck
    Heo, Jin-Seok
    Choi, Seong Ho
    Choi, Dong Wook
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    Jang, Kee-Taek
    Park, Hee Chul
    Lim, Do Hoon
    Park, Joon Oh
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (05): : 432 - 438
  • [22] Outcome Analysis of Adjuvant Chemoradiation after Incomplete Resection for Pancreatic Adenocarcinoma
    Koh, H.
    Kim, K.
    Chie, E.
    Jang, J.
    Kim, S.
    Oh, D.
    Im, S.
    Kim, T.
    Bang, Y.
    Ha, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S342 - S342
  • [23] Neoadjuvant Chemoradiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma
    Shafi, S.
    Kaubisch, A.
    [J]. PANCREAS, 2015, 44 (08) : 1413 - 1413
  • [24] The utilization and impact of adjuvant therapy following neoadjuvant therapy and resection of pancreatic adenocarcinoma: does more really matter?
    Drake, Justin A.
    Stiles, Zachary E.
    Behrman, Stephen W.
    Glazer, Evan S.
    Deneve, Jeremiah L.
    Somer, Bradley G.
    Vanderwalde, Noam A.
    Dickson, Paxton V.
    [J]. HPB, 2020, 22 (11) : 1530 - 1541
  • [25] Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma
    Perri, Giampaolo
    Prakash, Laura
    Qiao, Wei
    Varadhachary, Gauri R.
    Wolff, Robert
    Fogelman, David
    Overman, Michael
    Pant, Shubham
    Javle, Milind
    Koay, Eugene J.
    Herman, Joseph
    Kim, Michael
    Ikoma, Naruhiko
    Tzeng, Ching-Wei
    Lee, Jeffrey E.
    Katz, Matthew H. G.
    [J]. ANNALS OF SURGERY, 2020, 271 (06) : 996 - 1002
  • [26] Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma - Discussion
    Aranha, GV
    Pendurthi
    [J]. AMERICAN SURGEON, 1998, 64 (07) : 692 - 692
  • [27] Adjuvant therapy for surgically resected pancreatic adenocarcinoma
    Abbruzzese, James L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (09): : 1066 - 1067
  • [28] Neoadjuvant and Adjuvant Therapy in Resectable Pancreatic Adenocarcinoma
    Johnson, Ryan
    McClelland, Paul H.
    Ahmad, Syed A.
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (05) : 987 - 1005
  • [29] Evaluation of recurrence patterns after adjuvant chemoradiation therapy in patients with resected pancreatic adenocarcinoma at Johns Hopkins Hospital
    Gavini, S.
    Hsu, C.
    Swartz, M.
    Laheru, D.
    Pawlik, T.
    Schulick, R.
    Wolfgang, C.
    Winter, J.
    Cameron, J.
    Herman, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S260 - S261
  • [30] ADJUVANT CHEMORADIATION OF PANCREATIC CANCER - EFFECTIVENES AND TOLERANCE OF COMBINED THERAPY
    Namysl-Kaletka, A.
    Miszczyk, L.
    Idasiak, A.
    Wolny, E.
    Wozniak, G.
    Wydmanski, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S221 - S221
12345